A Importância da Cooperação com a China no Sistema Global de Saúde
Resumo
A Área da Grande Baía de Guangdong-Hong Kong-Macau (AGB), criada em 2017, é composta por Hong Kong, Macau e nove cidades da província chinesa de Guangdong. Desde então, o governo central chinês e os governos locais estabeleceram novas políticas para favorecer o desenvolvimento de cuidados de saúde na AGB. Este artigo tem como objetivo resumir as recentes oportunidades de educação e de negócios relacionadas com o desenvolvimento da saúde na AGB e com os benefícios económicos da AGB, especialmente nas indústrias de Medicina Tradicional Chinesa e de dispositivos médicos. Por último, são discutidas as vantagens de Macau enquanto plataforma de transformação da tecnologia farmacêutica para os Países de Língua Portuguesa.
Referências
Abstracts from The International Conference on Medicinal Plants and Bioeconomy & the 1st Sino-CPLP Symposium on Natural Products and Biodiversity Resources. (2018). Chinese Medicine, 13(55). doi: 10.1186/s13020-018-0213-x
Angulo, P. (2002). Nonalcoholic fatty liver disease. The New England Journal of Medicine, 346(16), 1221–1231. doi:https: 10.1056/NEJMra011775
Brunt, E. M. (2001). Nonalcoholic steatohepatitis: definition and pathology. Seminars in Liver Disease, 21(1), 3–16. doi: doi.org/10.1055/s-2001-12925
Chen, J., Hu, Y., Chen, L., Liu, W., Mu, Y., & Liu, P. (2019). The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomedicine & Pharmacotherapy, 114, 108846. doi: 10.1016/j.biopha.2019.108846
Chen, Y., Zhao, Z., Fan, H., Li, Z., He, Y., & Liu, C. (2020). Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial. Contemporary Clinical Trials Communications, 19, 100601. doi: 10.1016/j.conctc.2020.100601
Constitutional and Mainland Affairs Bureau. (2020). Notice of the State Administration for Market Regulation and Other Departments on Issuing the Work Plan for Regulatory Innovation and Development of Pharmaceutical and Medical Device in the Guangdong-Hong Kong-Macao Greater Bay Area (Guo Shi Jian Yao [2020] No.159). Retrieved October 27,2021, from https://www.bayarea.gov.hk/en/resource/mainland-policies-measures-20201125.html
Department of Health. (2021). Health Facts of Hong Kong 2020 Edition. Retrieved October 27, 2021, from https://www.dh.gov.hk/english/statistics/statistics_hs/files/2020.pdf
Dong, S., Cai, F., Chen, Q., Song, Y., Sun, Y., Wei, B., … Su, S. (2018). Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacologica Sinica, 39, 930–941. doi: 10.1038/aps.2017.150
Executive Council. (2021a). O Conselho Executivo concluiu a discussão sobre o projecto do regulamento administrativo intitulado “Alteração ao Decreto-Lei n.º 81/99/M, de 15 de Novembro” [The Executive Council concluded the discussion on the Administrative Regulation Draft entitled “Amendment to Decree-Law No. 81/99/M, of 15 November”]. Retrieved October 27, 2021, from https://www.gov.mo/pt/noticias/567878/
Executive Council. (2021b). O Conselho Executivo concluiu a discussão do Projecto do Regulamento Administrativo intitulado “Organização e Funcionamento do Instituto para a Supervisão e Administração Farmacêutica” [The Executive Council concluded the discussion on the Administrative Regulation Draft entitled “Organization and Functioning of the Institute for Pharmaceutical Supervision and Administration”]. Retrieved October 27, 2021, from https://www.gov.mo/pt/noticias/567876/
Fazel, Y., Koenig, A. B., Sayiner, M., Goodman, Z. D., & Younossi, Z. M. (2016). Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism: Clinical and Experimental, 65(8), 1017–1025. doi:10.1016/j.metabol.2016.01.012
Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J.,… Lozano, R. (2018). Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet, 391(10136), 2236–2271. doi:10.1016/s0140-6736(18)30994-2
Government Information Bureau. (2019). Secretário para os Assuntos Sociais e Cultura, Dr. Alexis Tam Chong Weng liderou delegação participante na 2.ª edição da “Conferência de Cooperação em Saúde da Grande Baía Guangdong-Hong Kong-Macau” [Secretary for Social Affairs and Culture, Dr. Alexis Tam Chong Weng led delegation participating in the 2nd edition of the “Guangdong-Hong Kong-Macao Great Bay Health Cooperation Conference”]. Retrieved October 27, 2021, from https://www.gcs.gov.mo/detail/pt/N19BYSlYiC?4
Government Information Bureau. (2020). A Autoridade Monetária de Macau, a Direcção dos Serviços de Protecção Ambiental e a Associação de Bancos de Macau assinaram uma proposta que visa promover o desenvolvimento das finanças verdes de Macau [The Monetary Authority of Macau, the Environmental Protection Bureau and the Macau Association of Banks signed a proposal to promote the development of Macau’s green finance]. Retrieved October 27, 2021, from https://www.gov.mo/pt/noticias/236790/
Government Information Bureau. (2021). CE: Macao fully implementing ‘patriots governing Macao’ and ‘Two Sessions’ aspirations. Retrieved October 27, 2021, from https://www.gov.mo/zh-hant/news/369121/
广东省药品监督管理局 [Guangdong Medical Products Adminstration]. (2020). 广东省药品监管 统计年度报告（ 2019 年）[Annual Statistical Report on Medical Products in Guangdong Province (2019)]. Retrieved October 27, 2021, from http://mpa.gd.gov.cn/gkmlpt/content/3/3015/post_3015517.html
Health Bureau. (2019). 2ª Conferência de Avanço, Inovação e Desenvolvimento da Medicina Tradicional Chinesa da Grande Baía de Guangdong-Hong Kong-Macau realizada em Zhuhai [2nd Conference on Advance, Innovation and Development of Traditional Chinese Medicine of the Great Bay of Guangdong-Hong Kong-Macao held in Zhuhai]. Retrieved October 27, 2021, from https://www.gov.mo/pt/noticias/217393/
Health Commission of Guandong Province. (2020). 2019 Guangdong Health Statistical Brief. Retrieved October 27, 2021, from http://www.gdhealth.net.cn/ebook/2019tongjijianben/mobile/index.html#p=143
Hong Kong SAR Government. (2019a). FHB and National Medical Products Administration sign co-operation agreements (with photos). Retrieved October 27, 2021, from https://www.info.gov.hk/gia/general/201905/07/P2019050700410.htm
Hong Kong SAR Government. (2019b). SFH to attend Greater Bay Area hygiene and health co-operation conference in Shenzhen. Retrieved October 27, 2021, from https://www.info.gov.hk/gia/general/201902/24/P2019022200287.htm?fontSize=3
Hong Kong SAR Government. (2021). FHB welcomes latest work progress of measure of using HK registered drugs and medical devices used in HK public hospitals in Guangdong-Hong Kong-Macao Greater Bay Area. Retrieved October 27,2021, from https://www.info.gov.hk/gia/general/202104/17/P2021041700309.htm?fontSize=3
Hong Kong Trade Development Council. (2019). Greater Bay Area Health Bodies Sign Six-Point Formal Co-operation Agreement. Retrieved October 27, 2021, from https://research.hktdc.com/en/article/MzA3ODkzMDEz
Hong Kong Trade Development Council. (2020). Designated Healthcare Institutions in GBA to be Allowed to Use Urgently-Needed Hong Kong and Macao Drugs. Retrieved October 27,2021, from https://research.hktdc.com/en/article/NjAxNDc2MzU3
立法會通過中藥藥事中成藥註冊法 [Legislative Council passes the Law on Registration of Proprietary Chinese Medicines]. (2021). Jornal do Cidadão. Retrieved October 27, 2021, http://www.shimindaily.net/v1/news/macau/%E7%AB%8B%E6%B3%95%E6%9C%83%E9%80%9A%E9%81%8E%E4%B8%AD%E8%97%A5%E8%97%A5%E4%BA%8B%E4%B8%AD%E6%88%90%E8%97%A5%E8%A8%BB%E5%86%8A%E6%B3%95/
Liu, C., Jiang, C., Liu, C., Liu, P., & Hu, Y. (2002). Effect of Fuzhenghuayu decoction on vascular endothelial growth factor secretion in hepatic stellate cells. Hepatobiliary & Pancreatic Diseases International, 1(2), 207–210.
Loomba, R., & Sanyal, A. J. (2013). The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol, 10(11), 686–690. doi:10.1038/nrgastro.2013.171
López-Velázquez, J. A., Silva-Vidal, K. V., Ponciano-Rodríguez, G., Chávez-Tapia, N. C., Arrese, M., Uribe, M., & Méndez-Sánchez, N. (2014). The prevalence of nonalcoholic fatty liver disease in the Americas. Annals of hepatology, 13(2), 166–178. doi: 10.1016/S1665-2681(19)30879-8
Macao SAR Government. (2021). [Infographic] Master Plan of the Development of the Guangdong-Macao Intensive Cooperation Zone in Hengqin. Retrieved October 27, 2021, from https://www.gov.mo/en/news/234180/
Macao Trade and Investment Promotion Institute. (2021). UM holds Sino-CPLP Symposium on Natural Products and Biodiversity Resources. Retrieved October 27, 2021, from https://m.ipim.gov.mo/en/portuguese-speaking-countries-news/2021-06-01-um-holds-sino-cplp-symposium-on-natural-products-and-biodiversity-resources/
Macao Young Entrepreneur Incubation Centre. (n.d.-b) Innovation and Entrepreneurship Competition (Macao) for Technology Enterprises from Brazil and Portugal. Retrieved 27 October 2021, from https://myeic.com.mo/en/news-en/iecte_bp/
Macao Young Entrepreneur Incubation Centre. (n.d.-a). Youth Innovation and Entrepreneurship Program of China and Portuguese-speaking Countries. Retrieved 27 October 2021, from https://myeic.com.mo/en/startup-support/government-support-mea-sures/youth-innovation-and-entrepreneurship-program-of-china-and-portuguese-speaking-countries/
Méndez-Sánchez, N., Arrese, M., Zamora-Valdés, D., & Uribe, M. (2007). Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver International, 27(4), 423–433. doi: 10.1111/j.1478-3231.2007.01483.x
平安证券研究所 [Ping An Securities]. (2019). 粤港澳大湾区专题报告：大湾区规划出台，生物医药领域迎来投资风口 [Guangdong-Hong Kong-Macao Greater Bay Area Special Report: Planning for the Greater Bay Area is released, creating investment opportunity in the field of biomedical sciences]. Retrieved October 27, 2021, from http://pdf.dfcfw.com/pdf/H3_AP201903011301320794_1.PDF
Reuters. (2019). China gives conditional OK to its first self-developed Alzheimer’s drug. Retrieved, October 27, 2021, from https://www.reuters.com/article/us-china-drug-alzheimer-idUSKBN1XC0JC
Science and Technology Development Fund. (n.d.). FDCT’s Supporting Funding Scheme for Projects Admitted to EU’s Horizon Europe. Retrieved October 27, 2021, from https://www.fdct.gov.mo/en/union_funding_detail/article/jezcb4f5.html
Simões, J. A., Augusto, G. F., Fronteira, I., & Hernández-Quevedo, C. (2017). Portugal: Health system review. Health Systems in Transition, 19(2), 1–184.
Statista. (2021). Total population of China’s Greater Bay Area from 2010 to 2020 (in millions). Retrieved October 27, 2021, from https://www.statista.com/statistics/1172165/china-population-in-the-greater-bay-area-cities/
Statistics and Census Service. (2020). Health Statistics. Retrieved October 27, 2021, from https://www.dsec.gov.mo/getAttachment/5d9e4a11-8e1e-42f4-aec1-1e622f2047d7/P_SAU_PUB_2019_Y.aspx
Syed. Y. Y. (2020). Correction to: Sodium Oligomannate: First Approval. Drugs, 80(4), 445-446. doi: 10.1007/s40265-020-01274-3
Wang, Q. L., Tao, Y., Shen, L., Cui, H., & Liu, C. (2012). Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway. Journal of Chinese Integrative Medicine, 10(5), 561–568. doi: 10.3736/jcim20120512
Wang, Q., Du, H., Li, M., Li, Y., Liu, S., Gao, P., … Cheng, J. (2013). MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet. Evidence-Based Complementary and Alternative Medicine. doi: 10.1155/2013/368103
Wang, T., Kuang, W., Chen, W., Xu, W., Zhang, L., Li, Y., … Xiao, S. (2020). A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia. Alzheimer’s Research & Therapy, 12(1), 110. doi: 10.1186/s13195-020-00678-3
Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., … Geng, M. (2019). Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Research, 29, 787–803. doi: 10.1038/s41422-019-0216-x
Wu, M., Zhou, Y., Qin, S., Lin, L., Ping, J., Tao, Z., … Wu, M. (2020). Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells. Evidence-Based Complementary and Alternative Medicine. doi: doi.org/10.1155/2020/3468791
Xiao, S., Chan, P., Wang, T., Hong, Z., Wang, S., Kuang, W., … Zhang, Z. (2021). A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia. Alzheimer’s Research & Therapy, 13(1), 62. doi: 10.1186/s13195-021-00795-7
Yang, T., Shen, D., Wang, Q., Tao, Y., & Liu, C. (2013). Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. Journal of Ethnopharmacology, 148(2), 691–700. doi: 10.1016/j.jep.2013.05.031
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73–84. doi: 10.1002/hep.28431
Zhang, X. Y., Dias, A., Lopes, N. (2021). Research Topic: Edible and Medicinal Plants: From Ethnopharmacological Practices to Interdisciplinary Approaches and Regulations. Frontiers in Pharmacology. doi: 10.13140/RG.2.2.13896.24328
Direitos de Autor (c) 2022 Simon Lee, Lin Li, Jiayin Deng, Kit Ieng Kuok, Hio Kuan Lao, Dongmin Lin
Este trabalho está licenciado com uma Licença Creative Commons - Atribuição 4.0 Internacional.
Os direitos permanecem com os autores.
Licença Creative Commons: Atribuição 4.0 Internacional.
